Corporate Development...Strategy...Marketing

A LBERT P . F ETAYA

* * ** ** ** i ve H ills b o r ou gh, NJ 08 84 4 ( 90 8 ) 3 07 67 96

p at fet aya @ya h oo. c om

MARKETING…STRATEGY…BUSINESS DEVELOPMENT

Diverse Fortune 50 experience in commercial assessments, transactions, and digital solutions

Industry background in Pharmaceuticals, Medical Devices, and Technology

Cross-functional approaches to projects and transactions based on career experiences in marketing,

consulting, sales, manufacturing engineering (GE), and four startups

Global project history includes experiences in Japan, EMEA, and US.

Recognized for effective, collaborative leadership of project teams and successful leadership reviews

MSE Engineering/Management from UPenn/Wharton; MBA Finance; BA Chemistry, Fluent in French.

PROFESSIONAL EXPERIENCE

BRISTOL MYERS SQUIBB (Lawrenceville, NJ) Jan 2012 - Present

Director, Global Marketing

Strategy group with accountability across oncology, virology, and immunoscience therapeutic areas for solution

development addressing diverse marketing issues spanning strategic planning, operational excellence, and commercial

innovation.

Led project to assess company’s worldwide commercial innovation portfolio, understand strengths/opportunities

against strategic imperatives, and develop recommendations to drive continuous improvement in outcomes.

Developed formal Prioritization Framework which leverages asset qualitative and quantitative characteristics and was

adopted by organization’s senior leadership in supporting resource allocation decisions in 2014 budget cycle.

Led firm wide assessment of global and market needs for digital marketing, leading to strategy outlining digital solutions

and organizational accountability.

Key role in enterprise transformation project of operational model for transition of prelaunch assets from global to

market brand teams. Received BMS President’s Award in May 2013 in recognition of project’s business impact.

Designed integrated global and market asset level strategic planning, resource planning, and functional planning

processes to maximize launch effectiveness and accelerate speed to patient.

Recipient of seven formal performance excellence recognition awards during time in role.

JOHNSON & JOHNSON (Somerville, NJ) 2004 - 2011

Associate Director, New Business Development

Accountable for driving revenue and profitability by developing global growth strategies, then leading transactions to

realize those strategies. Scope included deal sourcing, business case development, financial analysis, structuring,

negotiation, project team leadership, and internal senior team reviews. Managed MBA Co-Ops and junior staff.

Led extended cross-functional project team in 12 month process of assessing and managing internal approval process

for $800 Million public firm acquisition.

Assessed, championed, and gained consensus for new strategic white space, and closed equity investments totaling $19

Million to support strategy.

Developed strategy for and closed marketing partnership for diagnostic which supported portfolio and increased

competitiveness of core business platform.

Selected for role of WW team liaison to firm’s Asia Pac regional business development group, providing leadership to

execute deals and develop key processes.

Manager, New Business Development

Accountable for overall project leadership for global new business development deals. Key activities included strategic and

functional opportunity assessments, leadership of internal project teams, negotiations with external counterparties, and

management of projects through internal approval processes. Managed 2 MBA Co-Ops.

Developed strategy and managed to deal closure complex long term marketing partnership with US tissue bank for

firm’s first biologics product. Deal revenues exceeded forecast by 45%.

Led to closure license agreement with Japanese stem cell firm whose technology supported regenerative medicine

pipeline efforts. Deal closed in 1.5 months, at less than budgeted price, while securing much broader technology rights

than originally planned.

Page 1 of 2

Albert P. Fetaya, page 2

2001 – 2003

Avaya Inc., (Basking Ridge, NJ)

Director, Corporate Development

Enterprise applications and services firm with $5 Billion in revenues. Responsible for strategic, financial, and

implementation assessments of business development opportunities. Led project teams and executed critical activities to

structure, negotiate, and close targeted deals.

Closed acquisition of technology firm for 30% less than budgeted amount. Product integration met major milestones,

and innovative deal structure resulted in 99% employee retention one year post-close.

Represented company’s board observer seat for 3 equity investment portfolio firms totaling $20 million in invested

capital, one jointly funded with Microsoft and IBM.

NewView Technologies, (New York, NY) 2000 – 2001

Director, Business Development

Kleiner-Perkins/Goldman Sachs funded B2B Internet firm launched in late 1999 with $100 million investment. Provided

public netmarketplace, private exchange, and supply chain solutions for direct materials. Activities included assessment of

licensing and acquisition opportunities, development and management of strategic alliances, and technology partnerships.

SRI International, (Princeton, NJ) 1998 - 2000

Director, Business Development

Former RCA Corporate Research Labs pursuing strategy of growth through patent licensing and new ventures in

healthcare, electronics, and IT marketplaces. Assessed technology commercialization opportunities, developed start up

business plans, and pursued funding from institutional VC funds.

Initiated and managed partnership with healthcare early stage VC fund to assess application of Sarnoff imaging

technology to automated digital radiology in mammography and vision care.

Teamed with Fortune 50 firm to develop technology for semiconductor based implantable drug delivery device.

Millennium Growth Partners/D. Dunham & Co. (Clifton, NJ) 1995 - 1998

Management Consultant

Focus in Fortune 50 healthcare and telecommunications business development issues, including feasibility/risk assessment

of new business proposals, resource allocation strategies, strategic planning, and product realization processes.

For a Princeton, NJ VC fund, visited numerous early stage business incubators and academic tech transfer offices,

screening over 150 technologies and businesses for potential licensing and acquisition deals.

Tencor Instruments, National Account Manager (Santa Clara, CA)

Opal, Inc., Sales Manager, Santa Clara, CA

Roles in direct sales of high value capital equipment to corporate accounts interacting with C-suite executives

GE Corp., Semiconductor Div. (Palm Beach, Fla/Somerville, NJ)

Engineering positions in manufacturing and process development

EDUCATION

Master’s of Science in Engineering

University of Pennsylvania, 3.8/4.0 GPA

Moore School of Eng. and Applied Science: IT & Network Engineering

Wharton School of Business: Second year MBA program (10 courses) in strategy, management

MBA/ Finance

Graduate School of Management, Rutgers University

3.7/4.0 GPA; Beta Gamma Sigma Honor Society

BA/ Chemistry

Queens College, City University of NY

3.8/4.0 GPA, Magna Cum Laude; American Institute of Chemists Award

Mini-MBA, Digital Marketing

Rutgers University, April 2015

Contact this candidate